Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0UWYXJ
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
ALTA-002
|
|||||
| Synonyms |
ALTA 002; ALTA-002; Anti-SIRPa antibody conjugated toll-like receptor 9 agonists-ALX Oncology/Tallac Therapeutics; TAC002
Click to Show/Hide
|
|||||
| Organization |
ALX Oncology, Inc.; Tallac Therapeutics, Inc.
|
|||||
| Drug Status |
Phase 1
|
|||||
| Indication |
In total 1 Indication(s)
|
|||||
| Drug-to-Antibody Ratio |
Undisclosed
|
|||||
| Antibody Name |
Anti-CD47 ALTA-002 mAb
|
Antibody Info | ||||
| Antigen Name |
Leukocyte surface antigen CD47 (CD47)
|
Antigen Info | ||||
| Payload Name |
Differentiated TLR-9 agonist (T-CpG)
|
Payload Info | ||||
| Therapeutic Target |
Toll-like receptor 9 (TLR9)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Undisclosed
|
|||||
